Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Nat Cancer. 2022 Mar;3(3):373. doi: 10.1038/s43018-022-00343-8.
No abstract available

Publication types

  • Published Erratum